WALLIS DE, 1999, Am. Med., 106, 629, 10.1016/S0002-9343(99)00124-2
LI ZQ, 2002, Blood, 99, 1230, 10.1182/blood.V99.4.1230
WARKENTIN TE, 2000, Blood, 96, 1703, 10.1182/blood.V96.5.1703
FRANCIS IL, 2002, Blood, 100, 84b
WARKENTIN TE, 1999, Pharmacotherapy, 19, 181, 10.1592/phco.19.3.181.30928
WARKENTIN TE, 1990, Hematol Omni Clin North Am, 4, 243, 10.1016/S0889-8588(18)30515-X
WARKENTIN TE, 2002, Arch. Pathol Lab. Med., 126, 1415, 10.5858/2002-126-1415-PCMALT
AMIRAL J, 1996, Br. Haematol, 92, 954, 10.1046/j.1365-2141.1996.407945.x
WARKENTIN TE, 2001, N Engl. I Med., 344, 1286, 10.1056/NEJM200104263441704
WARKENTIN TE, 1996, Br. Haematol, 92, 494, 10.1046/j.1365-2141.1996.d01-1481.x
WARKENTIN TE, 1994, Am.j Med., 97, 489, 10.1016/0002-9343(94)90332-8
FABIS F, 2002, Intern. Med., 252, 149, 10.1046/j.1365-2796.2002.01021.x
WARKENTIN TE, 1996, Am.' Med., 101, 502, 10.1016/S0002-9343(96)00258-6
WARKENTIN TE, 1995, N Engl. I Med., 332, 1330, 10.1056/NEJM199505183322003
RISCH L, 2003, Blood Cava]. Fibrinolysis, 14, 113, 10.1097/00001721-200301000-00020
OLSON JD, 1998, Arch. Pathol Lab. Med., 1229, 782
MAGNANI HN, 1997, Platelets, 8, 74
FARNER B, 2001, Thromb. Haemost., 85, 950, 10.1055/s-0037-1615946
CHONG BH, 2001, Thromb. Haemost., 86, 1170, 10.1055/s-0037-1616046
WILDE MI, 1997, A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia. Drugs, 54, 903
ETCHER P, 1996, Ann. Hematol, 72, A4
ETCHER P, 2002, Blood, 100, 704a
LUBENOW N, 2002, Blood, 100, 502a
GREINACHER A, 2000, Blood, 96, 846, 10.1182/blood.V96.3.846
MATTSON JC, 2002, Blood, 100, 130b
NGUYEN PH, 2002, Blood, 100, 130b
SCHIELE F, 1997, International Multicentre Hirudin Study Group. Thromb. Haemost., 77, 834
HUHLE G, 2000, Thromb. Res., 99, 325, 10.1016/S0049-3848(00)00253-X
WARKENTIN TE, 2002, Cup: Opin. Palm. Med., 8, 405
SWAN SK, 2000, Pharmacotherapy, 20, 318, 10.1592/phco.20.4.318.34881
BROWN PM, 2002, Am. I Health Syst. Pharm., 59, 2078, 10.1093/ajhp/59.21.2078
SHETH SB, 2001, Thromb. Haemost., 85, 435, 10.1055/s-0037-1615601
HURSTING MJ, 1999, Clin. Chem., 45, 409, 10.1093/clinchem/45.3.409
HIATT BK, 2001, Blood, 98, 91b
BREDDIN HK, 2002, argatroban to phenprocoumon and acenocoumarol. Blood, 100, 280a
DAGER WE, 2002, Ann. Pharmacother., 36, 489, 10.1345/aph.1A204
MONREAL M, 1996, Potential clinical advantages over heparin. Drugs Aging, 8, 171
WHITE HD, 1997, Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators. Circulation, 96, 2155
FOX I, 1993, Thromb. Haemost., 69, 157, 10.1055/s-0038-1651573
LINCOFF AM, 2003, JAMA, 289, 853, 10.1001/jama.289.7.853
GINSBERG JS, 1994, Circulation, 90, 2385, 10.1161/01.CIR.90.5.2385
BITTL JA, 1995, Hirulog Angioplasty Study Investigators.N. Engl. J. Med., 333, 764
AHMAD S, 1999, Clin. Appl. Thromb. Hemost., 5, 259, 10.1177/107602969900500410
SMYTHE MA, 2002, Am. Hematol, 71, 50, 10.1002/ajh.10181
WARKENTIN TE, 1998, Thromb. Haemost., 79, 1, 10.1055/s-0037-1614206
GABUTTI L, 2002, Intensive Care Med., 28, 1419, 10.1007/s00134-002-1443-y
MATSUO T, 1992, Br. J. Haematol, 82, 627, 10.1111/j.1365-2141.1992.tb06482.x
MATSUO T, 1991, Biomater Anil Cells Immobilization Biotechnol, 19, 185
VANHOLDER R, 1997, Thremb. Haemest., 77, 650, 10.1055/s-0038-1656028
FISCHER KG, 2002, Semin. Thremb. Hemest., 28, 467, 10.1055/s-2002-35288
WILLEY ML, 2002, Pharmacetherapy, 22, 492, 10.1592/phco.22.7.492.33671
FISCHER KG, 1999, Kidney I. Stipp], 72, S46
DAGER WE, 2001, Ann. Pharmacether., 35, 885, 10.1345/aph.10282
WITTKOWSKY AK, 2000, Pharmacetherapy, 20, 1123, 10.1592/phco.20.13.1123.35039
LINDHOFF-LAST E, 2002, Semin. Thremb. Hemest., 28, 439, 10.1055/s-2002-35284
LINDHOFF-LAST E, 2000, Lancet, 355, 467, 10.1016/S0140-6736(00)82018-8
HUHLE G, 2000, Cynecel °Enter Invest, 49, 67
HARENBERG J, 2001, Ann. Hematel, 80, 87
GREINACHER A, 1993, Thremb. Res., 71, 123, 10.1016/0049-3848(93)90178-Q
CHAN WS, 2000, Arch. Intern. Med., 160, 191, 10.1001/archinte.160.2.191
SCHIFFMAN H, 1997, Menai Kinderheilkd, 145, 606, 10.1007/s001120050160
KAWADA T, 2000, Hematel Once] Clio North Am, 14, 445, 10.1016/S0889-8588(05)70144-1
BOSHKOV LK, 2002, Bleed, 100, 269a
KOSTER A, 2000, Cardietherac. Vasc. Anesth., 14, 243, 10.1053/cr.2000.5861
KOSTER A, 2000, Ann. Theme. Surg., 69, 37, 10.1016/S0003-4975(99)01289-8
FOLLIS F, 2000, Ann. Theme. Surg., 70, 2173, 10.1016/S0003-4975(00)01329-1
KOSTER A, 2001, j Theme. Cardievasc. Surg., 122, 1254, 10.1067/mtc.2001.118271
AOUIFI A, 2001, Ann. Therac Surg., 71, 678, 10.1016/S0003-4975(00)02022-1
ARNOLETTI JP, 1999, Ann. Theme. Surg., 68, 576, 10.1016/S0003-4975(99)00602-5
VASQUEZ JC, 2002, Ann. Theme. Surg., 74, 2177, 10.1016/S0003-4975(02)04125-5
Direct thrombin inhibitors in acute coronary syndromes, 2002, The direct thrombin inhibitor trialists' collaborative group. Lancet, 359, 294
